Breaking News
Get 40% Off 0
Is NVDA a 🟢 buy or 🔴 sell? Unlock Now
Close

Corcept Therapeutics Incorporated (CORT)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Corcept's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
22.99 +1.33    +6.14%
16:00:01 - Closed. Currency in USD ( Disclaimer )
After Hours
23.00
+0.01
+0.04%
18:48:30 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 1,233,692
  • Bid/Ask: 22.57 / 23.40
  • Day's Range: 21.67 - 23.09
Corcept 22.99 +1.33 +6.14%

CORT Cash Flow Statement

 
Featured here, the Cash Flow Statement for Corcept Therapeutics Incorporated, showing the changes in the company's cash and cash equivalents, broken down to operating, investing and financing activities over each of the last 4 periods (either quarterly or annually).
AnnualQuarterly
InvestingPro Advanced Cash Flow Statement
Period Ending: 2023
31/12
2023
30/09
2023
30/06
2023
31/03
Period Length: 0 Months 0 Months 0 Months 0 Months
Net Income/Starting Line - 31.38 27.53 15.88
Cash From Operating Activities - 52.91 42.29 25.96
Depreciation/Depletion - 0.169 0.823 0.74
Amortization - - - -
Deferred Taxes -3.67 -8.86 -10.24 -6.73
Non-Cash Items - 1.27 -0.057 2.91
Cash Receipts - - - -
Cash Payments - - - -
Cash Taxes Paid 47.6 - - -
Cash Interest Paid - - - -
Changes in Working Capital - 20.1 13.99 6.43
Cash From Investing Activities - -109.57 -24.1 207.48
Capital Expenditures - -0.037 -0.102 -
Other Investing Cash Flow Items, Total - -109.53 -24 207.48
Cash From Financing Activities - -3.92 -145.75 0.181
Financing Cash Flow Items - - - -
Total Cash Dividends Paid - - - -
Issuance (Retirement) of Stock, Net - -3.92 -145.75 0.181
Issuance (Retirement) of Debt, Net - - - -
Foreign Exchange Effects - - - -
Net Change in Cash - -60.58 -127.56 233.61
Beginning Cash Balance - 172.38 299.94 66.33
Ending Cash Balance - 111.8 172.38 299.94
Free Cash Flow 2.08 54.4 45.05 26.85
Free Cash Flow Growth -96.17 20.76 67.78 -20.66
Free Cash Flow Yield - 1.9 1.86 1.11
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on the cash flow statement, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

CORT Comments

Write your thoughts about Corcept Therapeutics Incorporated
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Carlos Andres
Carlos Andres Nov 18, 2020 11:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
bullish?
Carlos Andres
Carlos Andres Nov 18, 2020 11:53AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Yes, I was right :-)
Tristan Newman
Tristan Newman Apr 23, 2020 2:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Cort seems to be doing alright now while other biotechs got spooked by the Gilead news. Anyone know why that is?
Tristan Newman
Tristan Newman Apr 23, 2020 2:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Shooting up like a rocket this morning. I'm not complaining, but seriously: what gives?
Sergio GR
Sergio GR Feb 05, 2019 10:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lol it lost 5% in one second what happened?
Sergio GR
Sergio GR Feb 05, 2019 10:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
10%*
Trevor Headlee
Trevor Headlee Nov 03, 2017 11:42AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Doesn't make any sense.. Cort had a record quarter. Their best quarter ever
Trevor Headlee
Trevor Headlee Nov 01, 2017 3:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Hope we beat on earnings tomorrow
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email